Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Free Cash Flow: 2023-2025

Historic Free Cash Flow for Camp4 Therapeutics (CAMP) over the last 2 years, with Sep 2025 value amounting to -$11.2 million.

  • Camp4 Therapeutics' Free Cash Flow fell 15.72% to -$11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.7 million, marking a year-over-year decrease of 2.66%. This contributed to the annual value of -$46.0 million for FY2024, which is 2.69% down from last year.
  • Camp4 Therapeutics' Free Cash Flow amounted to -$11.2 million in Q3 2025, which was down 8.60% from -$10.3 million recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Free Cash Flow ranged from a high of -$9.7 million in Q3 2024 and a low of -$14.6 million during Q1 2025.
  • In the last 3 years, Camp4 Therapeutics' Free Cash Flow had a median value of -$11.4 million in 2024 and averaged -$11.8 million.
  • Within the past 5 years, the most significant YoY rise in Camp4 Therapeutics' Free Cash Flow was 23.29% (2025), while the steepest drop was 29.09% (2025).
  • Camp4 Therapeutics' Free Cash Flow (Quarterly) stood at -$12.0 million in 2023, then climbed by 3.63% to -$11.6 million in 2024, then decreased by 15.72% to -$11.2 million in 2025.
  • Its last three reported values are -$11.2 million in Q3 2025, -$10.3 million for Q2 2025, and -$14.6 million during Q1 2025.